XML 40 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Accounting Policies [Line Items]    
Clinical Trial Accruals $ 402,773 $ 499,028
Depreciation 117,779 66,451
Allocated Share-based Compensation Expense $ 30,500 $ 10,100
Options And Warrants [Member]    
Accounting Policies [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 17,849,331 15,923,807
Minimum [Member]    
Accounting Policies [Line Items]    
Property, Plant and Equipment, Useful Life 3 years  
Maximum [Member]    
Accounting Policies [Line Items]    
Property, Plant and Equipment, Useful Life 5 years